A Leading Kenyan Researcher in the US Honored as a Diaspora Shujaa
Dr F. George Njoroge, a leading Kenyan chemical researcher based in the United States, was on Sunday, October 21, 2012 honored as a Diaspora Shujaa by the New England Kenyan Welfare Association (NEKWA) during the 2012 Mashujaa Day celebrations in Boston, Massachusetts.
Dr Njoroge, currently a Senior Research Fellow at Eli Lilly based in Indianapolis, Indiana, in 2011 discovered a Hepatitis C drug known as Victrelis™, the first oral Hepatitis C drug to be approved by the FDA. The drug is currently on sale in over 43 countries and has so far made more than $240 million in sales.
In recognition of this great achievement, the American Chemistry Society (ACS) – the world’s largest scientific society, in August, 2012 named Dr Njoroge a “Hero of Chemistry”, along with his team that was involved in the discovery of the drug (READ: A Leading Kenyan Scientist Based in the U.S. Named a "Hero of Chemistry" by American Chemical Society).
Dr Njoroge shared his success story with the Kenyans gathered at the Disabled American Veterans Hall in Braintree, MA, where he was the chief guest. He also gave several words of advice to Kenyans looking to venture into the science field.
Video Courtesy of Nyoris Productions.